India & India — Central Drugs Standard Control Organisation

India: India is strengthening its digital public infrastructure for health by launching several new initiatives, including Aarogya Setu 2.0, a Drug Registry, and e-Sushrut Clinic, aiming to make healthcare more integrated, accessible, and citizen-centric.

India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation collaborated in the development of the Drug Registry, ensuring standardization of medicine data across India's healthcare system.

India: India's healthcare sector benefits from the availability of a new targeted cancer therapy, Tanstrive, which addresses a specific genetic alteration in various solid tumors. This improves treatment options for Indian patients.

India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation provided marketing authorization for Tanstrive, enabling its launch in India and ensuring regulatory compliance for the new drug.

India: The regulatory changes proposed by the Bangladesh — Ministry of Health and Family Welfare are intended to benefit the medical device industry and patients within India by improving ease of doing business and ensuring timely availability of quality medical devices.

India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation is involved as the draft notification for the amendments is available on its website for stakeholder comments.

India — Central Drugs Standard Control Organisation: India — Central Drugs Standard Control Organisation launched risk-based inspections of drugs across six states and is analyzing samples to determine the cause of deaths.

India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation alerted the India — Drugs Control Administration, Telangana, about the adulteration of Almont-Kid Syrup, playing a crucial role in identifying the issue.

India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation is collaborating with state regulators in India to curb malpractices in the GLP-1 drug supply chain.